Abstract
Introduction
The peptide transporters expressed in the brush border membrane of the intestinal and renal epithelial cells are responsible for the absorption of small pepw x tides which consist of two or three amino acids 1-5 .
These transporters are energy-dependent, driven by a transmembrane H q gradient, and catalyze the coq w x transport of the peptide substrates with H 6-8 . In addition to the endogenously occurring dipeptides and tripeptides, several pharmacologically active exogenous compounds which possess peptide-like chemical structures are also accepted as substrates by w x the intestinal and renal peptide transporters 9-11 . These compounds include the b-lactam antibiotics, cephalosporins and penicillins, angiotensin-converting enzyme inhibitors, renin inhibitors, and the antineoplastic agent bestatin. The peptide transporters are important determinants of the therapeutic efficacy of these peptidomimetic drugs by influencing their bioavailability and circulatory half-life.
Among the cephalosporin antibiotics, some are Ž zwitterionic e.g., cephalexin, cefadroxil, and cefa-. Ž clor while some are anionic e.g., cefixime, . ceftibuten, and cefdinir . It has been well established that zwitterionic cephalosporins are effectively transported by intestinal as well as renal peptide transw x porters 12-16 . However, it is not clear whether anionic cephalosporins are effective substrates for both of these peptide transporters. Studies from several laboratories have shown that the anionic cephalosporins cefixime, cefdinir and ceftibuten are transported by the intestinal peptide transport system w x 17-25 . But there is controversy regarding the interaction of these anionic cephalosporins with the renal w x peptide transport system. Tamai et al. 26 have demonstrated, with isolated renal brush border membrane vesicles, that cefixime is not recognized as a substrate by the renal system, whereas Naasani et al. w x 27-29 have shown, using the same experimental approach, that ceftibuten is a substrate for the renal system. Cefixime and ceftibuten are structurally very similar and both are dianionic. Therefore, it is surprising that the studies by Tamai et al. and by Naasani et al. have led to different conclusions with regard to whether or not anionic cephalosporins are substrates for the renal peptide transport system. It has to be pointed out here that the peptide transporters are not the only transport systems available for the absorption of anionic cephalosporins in the intestine and the kidney. The monocarboxylate transporter present in the intestine has been shown to participate in the absorption of the monoanionic w x cephalosporin cefdinir 20 . However, this particular system is most likely restricted to monoanionic cephalosprins. Dianionic cephalosporins such as cefixime and ceftibuten are not likely to be effective substrates for the monocarboxylate transporter.
The purpose of the present investigation was to study the interaction of anionic cephalosporins with the intestinal and renal peptide transporters using four different approaches. In the first approach, cultured cell lines of intestinal and renal origin which constitutively express H q -coupled peptide transport activity were used. Caco-2 cells are of human intestinal origin and are known to possess a low affinity H q rpeptide Ž .w x cotransport system PEPT 1 30 . SKPT cells are of rat renal origin and are known to possess a high q Ž . affinity H rpeptide cotransport system PEPT 2 w x 31 . In the second approach, cloned human intestinal and renal H q rpeptide cotransporters, namely PEPT 1 w x w x 32 and PEPT 2 33 respectively, were functionally expressed in HeLa cells which were then used in the described studies. In the third approach, brush border membrane vesicles isolated from rat kidneys were employed. In each of these approaches, peptide transport activity was measured by the uptake of the Ž . dipeptide glycylsarcosine Gly-Sar in the presence of an inwardly directed H q gradient and the interaction of anionic cephalosporins with the peptide transporters was investigated by analyzing the ability of these compounds to compete with Gly-Sar for the uptake process. In the fourth approach, the cloned human PEPT 1 was functionally expressed in Xenopus laeÕis oocytes and the PEPT 1-mediated transport of the anionic cephalosporin ceftibuten was directly investigated by electrophysiological approaches. The results of the investigation clearly show that anionic cephalosporins are transported by intestinal as well as renal peptide transport systems. w x glucose 30,31 . The culture medium was first aspirated from the dish and the cell monolayer was washed once with 1 ml of the uptake buffer. Uptake was initiated by the addition of 1 ml of the uptake buffer containing radiolabeled substrate. Incubation was continued for 10 min, after which uptake was terminated by the removal of the medium followed by three times washing with ice-cold uptake buffer. The cells were then solubilized with 1 ml of 0.2 M NaOH, 1% SDS and the contents were transferred to a counting vial for determination of radioactivity.
Materials and methods

Materials
w 14 x w 14 x Ž 2-C Glycyl 1-C
Vaccinia Õirus expression of PEPT 1 and PEPT 2
This was done using the procedure described earw x lier 32,33 . Subconfluent HeLa cells in 24-well culture plates were first infected with a recombinant vaccinia virus VTF which carries the gene for T7 RNA polymerase as a part of its genome. This enables the HeLa cells to express T7 RNA polymerase. Following the infection, the cells were transfected with pBluescript-PEPT 1 cDNA construct or with pBluescript-PEPT 2 cDNA construct. In these constructs, the cDNAs were under control of T7 promoter in the plasmid. Cells transfected with empty plasmid served as control. Transfection was mediated by lipofection. The virus-encoded T7 RNA polymerase catalyzes the transcription of the cDNA, allowing transient expression of the PEPT 1 or PEPT 2 protein in the HeLa cell plasma membrane. After 12 h post-infection, transport measurements were made w 14 x at room temperature with C Gly-Sar. The uptake Ž . medium was 25 mM MesrTris pH 6.0 containing 140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl , 0.8 2 mM MgSO , and 5 mM glucose. The time of incuba-4 tion for uptake measurements was 3 min. At the end of the incubation, the uptake was terminated by removal of the uptake medium by aspiration followed by washing two times with ice-cold uptake medium which did not contain radiolabeled substrate. The cells were then solubilized with 0.5 ml of 1% SDS, transferred to counting vials, and used for determination of radioactivity.
Preparation of renal brush-border membrane Õesicles
Brush-border membrane vesicles were prepared from kidneys by the Mg 2q -aggregation method in the w Ž . x presence of ethylene bis oxyethylenenitrilo te-Ž . w x traacetic acid EGTA as described previously 34 . Kidneys were obtained from two different rat strains, Sprague-Dawley and SHR. The renal tissue comprising the cortical and outer medullary regions was used for the isolation of membrane vesicles because we have shown earlier that both regions possess peptide w x transport activity 35 . The tissue was homogenized Ž in 10 volumes of homogenizing buffer 12 mM TrisrNaOH, 5 mM EGTA, 300 mM mannitol, pH . 7.5 for 90 s using an Ultra Turrax, with the speed set at 50. The resulting homogenate was diluted with an equal volume of ice-cold water. A stock solution of 1 M MgCl was added to the above suspension to give 2 a final concentration of 10 mM MgCl . The mixture 2 was stirred for 1 min and allowed to stand for 15 min. The suspension was then centrifuged at 3000 = g for 10 min. The pellet was discarded, and the supernatant was centrifuged again at 60 000 = g for 30 min. The pellets containing brush-border membranes were washed twice with the preloading buffer by dilution and centrifugation. The preloading buffer Ž . was 50 mM 4-2-hydroxyethyl -1-piperazineethane-Ž . Ž . sulfonic acid Hepes , 75 mM Tris pH 8.3 , contain-( )ing 100 mM K SO . A 25-gauge needle was used to 2 4 suspend the pellets. The protein concentration of the final membrane preparation was adjusted to 6 mgrml, and it was stored in liquid N in small aliquots until 2 use.
Uptake measurements in membrane Õesicles
w 14 x Uptake of C Gly-Sar was measured at room Ž . w x temperature 22-238C as described earlier 36 using a rapid filtration technique. Millipore membrane fil-Ž . ters DAWP type; 0.65 mm pore size were used. Membrane vesicles were incubated with 50 mM valinomycin prior to use in uptake measurements. Uptake was initiated by mixing 40 ml of the membrane Ž suspension with 160 ml of uptake buffer 50 mM Hepes, 50 mM Mes, 25 mM Tris, 300 mM mannitol, . pH 6.0 containing radiolabeled peptide substrate. All uptake measurements were carried out with 10-s incubations. Uptake was terminated by the addition of Ž 3 ml of ice-cold stop buffer 2 mM HepesrTris, 210
. mM KCl, pH 7.5 . The mixture was filtered and the filter retaining the membrane vesicles was washed with 3 = 5 ml of the stop buffer. The washed filter was transferred to a counting vial, and the radioactivity associated with the filter was counted by liquid scintillation spectrometry.
Oocyte expression and electrophysiological measurements
The procedures for preparation of oocytes from Xenopus laeÕis, synthesis of human PEPT 1 cRNA, and microinjection of cRNA into the oocytes have w x been described previously 37,38 . A two-microelecw x trode voltage-clamp system 39 was used to measure steady-state currents associated with PEPT 1-mediated transport at pH 6.0.
Step changes in membrane potential were applied, each for a duration of 100 ms Ž . q 50 mV to y130 mV in 20 mV increments . The value for K , the substrate concentration at which 0.5 current is half-maximal, was determined by measuring the currents over a ceftibuten concentration range of 0.05-5 mM and fitting the data to MichaelisMenten equation describing a single transport system.
Data analysis
Experiments were done in duplicate or triplicate and each experiment was repeated two to three times.
Results are given as means" S.E. The kinetic parameters, the Michaelis-Menten constant, K , and the 
Results and discussion
Studies with cultured cells which differentially express PEPT 1 or PEPT 2
Recent molecular cloning studies have established that the H q -coupled peptide transporters expressed in the intestine and kidney are structurally different, w x encoded by different genes 32,33,37,40-43 . The Ž . cloned human intestinal peptide transporter PEPT 1 Ž . and the human kidney peptide transporter PEPT 2 exhibit only 50% homology in amino acid sequence. PEPT 1 is expressed primarily in the intestine and, to a much lesser extent, in the kidney. PEPT 2 is expressed in the kidney and other tissues such as the brain, lung, liver and heart but not in the intestine w x 33,43 . Even though both of these transporters catalyze the transport of small peptides in a H q gradient-dependent manner, there are important differences between these transporters in substrate affinity w x w x 40,43,44 as well as in substrate specificity 44 . In particular, b-lactam antibiotics are differentially recw x ognized by PEPT 1 and PEPT 2 44 . We have identified recently two cultured cell lines, one expressing PEPT 1 and not PEPT 2 and the other w x expressing PEPT 2 and not PEPT 1 44 . These are Ž the human colon carcinoma cell line Caco-2 PEPT . 1 and the SHR rat kidney proximal tabular cell line Ž . SKPT PEPT 2 . These cell lines provide excellent model systems to differentially study the substrate selectivity of PEPT 1 and PEPT 2. In the present study, we have used these two cell lines to investigate the interaction of anionic cephalosporins with PEPT 1 and PEPT 2. These studies were done with two Ž . dianionic cephalosporins cefixime and ceftibuten Ž . and one monoanionic cephalosporin cefdinir . The cells were cultured as confluent monolayers and the activity of the H q -coupled peptide transporters was measured by determining the uptake of the dipeptide Gly-Sar in the presence of an inwardly directed H gradient. This was done by measuring the uptake from an extracellular medium of pH 6.0. Gly-Sar was chosen as the peptide substrate because of its resistance to hydrolysis by membrane-bound peptidases. The chemical structures of these antibiotics are given in Fig. 1 for comparison with the chemical structure of Gly-Sar. Measurements of Gly-Sar uptake in Caco-2 cells and in SKPT cells were made using an incubation time of 10 min. The uptake was found to Ž . be linear over this incubation period Fig. 2 . We first investigated the influence of increasing concentrations of the anionic cephalosporins on the uptake of Ž . Gly-Sar in these cells Fig. 3 . The activity of the peptide transporters measured at 5 mM Gly-Sar in the absence of cephalosporins was 187.4 " 6.1 pmolrmg Ž . of proteinr10 min in Caco-2 cells PEPT 1 and 121.4 " 1.2 pmolrmg of proteinr10 min in SKPT Ž . cells PEPT 2 . All three anionic cephalosporins inhibited the peptide transporter activity in both cell lines to a significant extent. In the case of PEPT 1, the inhibitory potency was in the following order: ceftibuten ) cefixime ) cefdinir. The IC values 50 Ž i.e., the concentration necessary to cause 50% inhibi-. tion for these cephalosporins were 0.9 " 0.1 mM, ; 10 mM, and ) 10 mM respectively. In the case of Ž . PEPT 2, the order of the inhibitory potency was the same as in the case of PEPT 1, i.e., ceftibuten) cefixime) cefdinir. The IC values were 0.48 " 50 0.03 mM, 3.2 " 0.1 mM, and ; 10 mM respectively. Even though the order of the inhibitory potency was the same, PEPT 2 was comparatively more sensitive to inhibition by the anionic cephalosporins than PEPT 1. These findings are in agreement with the earlier observations that PEPT 1 is a low-affinity transporter, whereas PEPT 2 is a high-affinity transporter w x 32,40,43 . The most important finding from these There is no controversy with regard to the recognition of the anionic cephalosporins as substrates by the intestinal peptide transport system
In the present study, we investigated the kinetic nature of the inhibition of Gly-Sar transport mediated by the kidney-specific peptide transporter PEPT 2 by two of the anionic cephalosporins, namely cefixime and ceftibuten. Gly-Sar uptake was measured over the concentration range of 25-500 mM in the absence or in the presence of the cephalosporins. The concentrations of the cephalosporins chosen for these studies were approximately equal to the IC values 50 Ž . ceftibuten, 0.5 mM; cefixime, 3 mM . Fig. 4A describes the relationship between the uptake rate and Ž w x. Gly-Sar concentration v versus S . The values for v given in Fig. 4A represent the rates of total uptake and have not been corrected for the nonsaturable diffusional component. Analysis of the kinetic parameters of the uptake process was, however, done only for the saturable component. For this purpose, the diffusional component of Gly-Sar uptake was determined by measuring the uptake in the presence of Ž . excess Gly-Pro 10 mM , a competing substrate for the peptide transport process. The diffusional component represented 4% of total uptake at 25 mM Gly-Sar and 18% of total uptake at 500 mM Gly-Sar. Fig. 4B describes the data for saturable component given as Eadie-Hofstee plots. For control Gly-Sar uptake as well as for Gly-Sar uptake measured in the presence of ceftibuten or cefixime, the Eadie-Hofstee plots Ž 2 . were linear r ) 0.98 , indicating participation of a single transport system in Gly-Sar uptake. In the absence of the cephalosporins, the Michaelis-Menten constant, K , for Gly-Sar was 74.5 " 2.9 mM and the t maximal velocity, V , was 1.77 " 0.02 nmolrmg max of proteinr10 min. These values agree well with the Ž . of 3 mM cefixime v or 0.5 mM ceftibuten B . The uptake was measured at pH 6.0 with a 10-min incubation period. Concentration of Gly-Sar was varied between 25 and 500 mM, w 14 x keeping the concentration of C Gly-Sar constant at 5 mM and adding unlabeled Gly-Sar to desired concentrations. Non-mediated component was determined from the uptake of radiolabel measured in the presence of 10 mM Gly-Pro. This component was subtracted from total uptake to calculate mediated uptake which was used in kinetic analysis. Results are given as uptake Ž . rate versus Gly-Sar concentration A and as Eadie-Hofstee plots Ž . w x B For v versus s plots, uptake rates without correction for the diffusional component were used and for Eadie-Hofstee plots, uptake rates after correction for the diffusional component were used. Gly-Sar uptake competitively. Thus, the interaction of the anionic cephalosporins with the renal peptide Ž . transporter PEPT 2 is kinetically similar to that with Ž . the intestinal peptide transporter PEPT 1 .
We have also determined the inhibition constants Ž . K for ceftibuten, the most potent anionic i cephalosporin to inhibit Gly-Sar uptake by PEPT1 and by PEPT2. This was done by measuring mediated uptake of Gly-Sar in Caco-2 cells and in SKPT Ž cells at two different Gly-Sar concentrations 50 mM and 500 mM for Caco-2 cells; 10 mM and 70 mM . for SKPT cells in the presence of increasing concen-Ž . trations of ceftibuten 0-2.5 mM . The results are Ž given as Dixon plots 1ruptake rate versus inhibitor . concentration . The plots were linear at both Gly-Sar Ž . concentrations in Caco-2 cells . for SKPT cells present study .
Studies with the cloned human intestinal and renal peptide transporters, PEPT 1 and PEPT 2
The SKPT cell line which expresses PEPT 2 is of rat kidney origin. There is no human kidney cell line known to express PEPT 2. Even though the studies thus far described have shown that anionic cephalosporins interact with PEPT 2 present in the SKPT cells, it is important to know whether such interaction also occurs in the case of the human kidney peptide transporter. We have recently isolated the cDNA which codes for the human kidney-specific w x peptide transporter 33 . This cDNA can be functionally expressed in HeLa cells using the vaccinia virus w x expression system 33,40,44 . HeLa cells are ideal for these studies because there is no endogenous peptide transport activity in these cells. After functional expression of the human PEPT 2 cDNA in HeLa cells, the cells were used to study the interaction of anionic Ž . cephalosporins with PEPT 2 Fig. 6 . In control cells, transfected with pBluescript vector alone, the peptide transport activity measured as Gly-Sar uptake at a concentration of 50 mM was 17.3 " 0.5 pmolr10 6 cellsr3 min. This uptake was entirely due to nonsaturable diffusional process. The transport activity increased 4-fold to 65.4 " 1.6 pmolr10 6 cellsr3 min in cells transfected with pBluescript-PEPT 2 cDNA construct. The difference between these two values represented the PEPT 2-mediated activity. This PEPT 2-specific Gly-Sar uptake activity was found to be inhibited to a significant extent by anionic cephalosporins. At a concentration of 10 mM, the inhibition of Gly-Sar uptake caused by cefixime, ceftibuten, and cefdinir was 54%, 96% and 48% Ž . respectively Fig. 6 . These data clearly demonstrate ( ) Fig. 6 . Influence of anionic cephalosporins on Gly-Sar uptake mediated by the cloned human kidney peptide transporter PEPT 2. HeLa Ž . cells were transfected with either empty pBluescript alone pBS or with PEPT 2 cDNA. The cDNA was functionally expressed in these cells by the vaccinia virus expression system. Uptake of 50 mM Gly-Sar was measured in these cells at pH 6.0 with a 3-min incubation. Ž .
Ž . A Gly-Sar uptake in control and in PEPT 2-expressing cells. B PEPT 2-mediated Gly-Sar uptake in the absence or presence of anionic Ž .
6 cephalosporins 10 mM , given as percent of uptake measured in the absence of the inhibitors. The 100% value was 47.9 " 1.3 pmolr10 cellsr3 min. Ž . cDNA`. The cDNAs were functionally expressed in these cells by the vaccinia virus expression system. Uptake of Gly-Sar was measured with a 3-min incubation. Concentration of Gly-Sar was 20 mM for PEPT 1 and 40 mM for PEPT 2. Concentration of ceftibuten was varied between 0 and 10 mM. Uptake measured in cells transfected with empty pBluescript was subtracted from uptake measured in cDNA-transfected cells to determine cDNAspecific uptake. Results are given as percent of uptake measured in the absence of ceftibuten. The 100% value was 144"10 pmolr10 6 cellsr3 min for PEPT 1 and 31"4 pmolr10 6 cellsr3 min for PEPT 2. that anionic cephalosporins interact with the human kidney peptide transporter PEPT 2.
We also studied the interaction of anionic cephalosporins with the human intestinal peptide transporter under similar conditions. The human PEPT 1 cDNA was functionally expressed in HeLa cells using the vaccinia virus expression system. Gly-Sar uptake measured at a concentration of 20 mM was 9.8 " 1.4 pmolr10 6 cellsr3 min in HeLa cells transfected with pBluescript vector alone. This value increased 23-fold to 227.3 " 26.0 pmolr10 6 cellsr3 min in cells transfected with pBluescript-PEPT 1 Ž . cDNA construct Fig. 7 . The PEPT 1-specific GlySar uptake was found to be inhibited by 44%, 87%, and 31% in the presence of cefixime, ceftibuten, and Ž . cefdinir 10 mM each respectively. Thus, anionic cephalosporins are recognized by human PEPT 1 and human PEPT 2. Fig. 8 describes the dose-response relationship for the inhibition of PEPT 1-and PEPT 2-mediated Gly-Sar uptake by ceftibuten, the most potent inhibitor among the anionic cephalosporins tested in this study. The concentration of Gly-Sar was 20 mM for PEPT 1 and 40 mM for PEPT 2. The IC value 50 for the inhibition was found to be 0.76 " 0.13 mM for PEPT 1 and 0.14 " 0.01 mM for PEPT 2. The corresponding K values were calculated from these i IC values according to the method of Cheng and 50 w x Prusoff 45 . The K value used in this calculation t w x was 0.29 mM for PEPT 1 32 and 74 mM for PEPT w x 2 40 . These K values were determined under t experimental conditions similar to those used in the present study. The K value for the inhibition of i Gly-Sar uptake by ceftibuten was 0.71 " 0.12 mM for PEPT 1 and 0.09 " 0.01 mM for PEPT 2.
Studies with brush border membrane Õesicles isolated from rat kidney w x
The studies by Tamai et al. 26 which showed no interaction of cefixime with the renal peptide transporter were done with brush border membrane vesicles isolated from Sprague-Dawley rat kidneys. The Ž . Ž . A and SHR B rat kidneys. Uptake of Gly-Sar 30 mM was measured in these vesicles in the presence of an inwardly directed H q gradient and an inside-negative K q -diffusion potential with a 10-s incubation. When present, the concentration of cefixime was 10 mM and that of ceftibuten was 2.5 mM. Results are given as percent of uptake measured in the absence of Ž . inhibitors control . The 100% value was 104.5"1.6 pmolrmg of proteinr10 s in Sprague-Dawley rats and 76.0"1.3 pmolrmg of proteinr10 s in SHR rats.
( )studies described thus far in this paper were done either with SKPT cells which originated from SHR rat kidney or with the cloned human PEPT 2. In order to find out whether species andror animal strain differences might have contributed to the varying results obtained in these studies, we investigated the interaction of anionic cephalosporins with the renal peptide transporter using brush border membrane vesicles prepared from Sprague-Dawley rat kidneys Ž . and from SHR rat kidneys Fig. 9 . Gly-Sar uptake in these membrane vesicles were measured in the presence of an inwardly directed H q gradient and a valinomycin-induced inside-negative K q -diffusion potential. The Gly-Sar uptake activity was slightly higher in Sprague-Dawley rat kidney membrane vesicles than in SHR rat kidney membrane vesicles. At a Gly-Sar concentration of 30 mM, the uptake activity was 104.5 " 1.6 pmolrmg of proteinr10 s in Sprague-Dawley rats and 76.0 " 1.3 pmolrmg of proteinr10 s in SHR rats. Cefixime and ceftibuten inhibited the Gly-Sar uptake activity significantly in both rat strains. There was no difference in the extent of inhibition between Sprague-Dawley and SHR rats. In both rat strains, the inhibition caused by 10 mM cefixime was about 30%. Ceftibuten was considerably more potent than cefixime in inhibiting Gly-Sar uptake. The inhibition caused by 2.5 mM ceftibuten was about 35%.
There was a significant quantitative difference in the inhibitory potency of the anionic cephalosporins between SKPT cells and SHR rat kidney brush border membrane vesicles. This difference is not explainable on the basis of animal species or animal strain differences because SKPT cells were originally derived from SHR rat kidney. The data show that the anionic cephalosporins are more potent in inhibiting Gly-Sar uptake in SKPT cells than in isolated renal brush border membrane vesicles. Intact cells are metabolically active and maintain stable intracellular Ž q . pH hence transmembrane H gradient and membrane potential. Furthermore, Gly-Sar uptake is linear in intact cells over the time period of uptake measurement. In contrast, isolated brush border membrane vesicles cannot maintain the experimentally imposed transmembrane H q gradients and membrane potential. Even with an incubation period as short as 10 s, Gly-Sar uptake is not linear. Another factor is the concentration of Gly-Sar used in these studies. In SKPT cells, Gly-Sar concentration was 5 mM which is almost 15-fold less than the Michaelis-Menten constant. On the other hand, Gly-Sar concentration was 30 mM when renal brush border membrane vesicles were employed. These factors are most likely responsible for the relatively lesser potency of the anionic cephalosporins in inhibiting Gly-Sar uptake in membrane vesicles than in intact cells.
Studies of ceftibuten transport in Xenopus oocytes expressing human PEPT 1
Several studies have investigated the transport of the anionic cephalosporin cefixime via the peptide transport system in intestinal brush border membrane w x vesicles 17,19,21 . These investigations have provided unequivocal evidence for the involvement of Ž . the intestinal peptide transporter PEPT 1 in the transport of cefixime. However, in contrast to several peptide substrates whose transport via PEPT 1 is known to be associated with the transfer of positive charge across the membrane, the transport of cefixime was interestingly found to be associated with w x the transfer of negative charge 17 . Such a transport mechanism would render the PEPT 1-mediated transport of anionic cephalosporins unfavorable in the intestine because of the presence of an inside-negative membrane potential across the brush border membrane. Therefore, we investigated the issue of charge transfer associated with PEPT 1-mediated transport of the anionic cephalosporin ceftibuten in Xenopus oocytes expressing human PEPT 1. These oocytes are readily amenable for direct measurements of transport-associated charge transfer using electrophysiological means. In this approach, the oocyte is voltage-clamped and transport-associated changes in membrane potential are compensated by passing currents of appropriate polarity and magnitude to maintain the membrane potential at the clamped level. This current is the measured parameter of transport. This experimental approach provides direct information on the nature of charge transfer associated with a Ž . transport process. In control water-injected oocytes, ceftibuten-evoked currents were not detectable, indicating the absence of endogenous electrogenic ceftibuten transport pathways in Xenopus oocytes. However, in oocytes expressing human PEPT 1, pHdependent, ceftibuten-evoked currents were readily Ž . observed Fig. 10A . At pH 7.5, 5 mM ceftibuten evoked a tiny outward current, showing that PEPT 1-mediated ceftibuten transport is indeed associated with the transfer of negative charge under these conditions. But, at pH 6.0, 5 mM ceftibuten evoked marked inward current which shows that PEPT 1-mediated ceftibuten transport in the presence of a H q gradient is associated with the transfer of positive charge. It appears that, in the absence of a H q gradient, transport of the anionic substrate uncoupled from H q may occur via PEPT 1 to some extent. The ceftibuten-evoked currents at pH 6.0 were concentration-dependent and obeyed Michaelis-Menten kinet-Ž ics. The K substrate concentration at which cur-0. .5
. rent was half-maximal for ceftibuten was 0.4 " 0.1 Ž . mM at y50 mV data not shown . The current-volt-Ž . age relationship for 5 mM saturating ceftibuten Ž . Fig. 10B was qualitatively similar to that for the w x zwitterionic peptide Gly-Sar 38 or for the zwitteriw x onic cephalosporin cefadroxil 41 . The ceftibutenevoked currents displayed a non-linear dependence upon membrane potential, with no reversal of cur-Ž rents at depolarized membrane potential up to q50 . mV and no indication of saturating with hyperpolar-Ž . ization up to y 130 mV .
We were unable to perform similar electrophysiological studies with PEPT 2 because injection of human PEPT 2 cRNA into oocytes failed to generate detectable currents. The human PEPT 2 cDNA is functional as evident from the cDNA-induced Gly-Sar uptake in HeLa cells. The reasons for the inability of the PEPT 2 cRNA to be functionally expressed in oocytes measured either by tracer uptake or by the electrophysiological approach are not known. The human PEPT 2 cDNA has a truncated 3 X non-coding Ž . region and lacks a poly A tail and it is possible that this compromises the stability of the cRNA in the oocytes. The recently cloned rabbit PEPT 2 cDNA Ž . possesses a poly A tail and the injection of the cRNA derived from this cDNA has been shown to lead to the functional expression of the peptide transporter as detected by the electrophysiological apw x proach 43 .
In conclusion, the present study has provided unequivocal evidence for the interaction of anionic cephalosporins with the intestinal and renal H q rpeptide cotransporters. We have documented this interaction using four different approaches. This investigation has produced several important findings. The results of this investigation demonstrate for the first time that the human PEPT 1 cloned from normal intestine can transport anionic cephalosporins, thus corroborating the observations in the human colon carcinoma cell line Caco-2. This study also establishes definitively that the renal peptide transporter interacts with anionic cephalosporins. The interaction is documented with cultured rat kidney cells which exclusively express PEPT 2, with the human PEPT 2 cloned from kidney, and with rat renal brush border membrane vesicles. The present study also shows using direct electrophysiological approaches that ceftibuten transport mediated by human intestinal peptide transporter PEPT 1 in the presence of an inwardly directed H q gradient is associated with 
